In the current study, we show that TAE226 treatment reduced the degree of mesangial process invasion (Figure 9 panels D–F) and reduces the migratory potential of cultured mesangial cells (Figure 9 panel J), suggesting that mesangial processes invasion of glomerular capillaries in Alport syndrome might be partially FAK-dependent. This evidence concerns the gene PTK2 and Alport syndrome.